Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Ronda Davis is active.

Publication


Featured researches published by Ronda Davis.


Bioorganic & Medicinal Chemistry Letters | 2000

The discovery of potent cRaf1 kinase inhibitors.

Karen Lackey; Michael Cory; Ronda Davis; Stephen V. Frye; Philip A. Harris; Robert Neil Hunter; David K. Jung; O.Bradley McDonald; Robert W. Mcnutt; Michael Robert Peel; Randy D. Rutkowske; James M. Veal; Edgar R. Wood

A series of benzylidene-1H-indol-2-one (oxindole) derivatives was synthesized and evaluated as cRaf-1 kinase inhibitors. The key features of the molecules were the donor/acceptor motif common to kinase inhibitors and a critical acidic phenol flanked by two substitutions. Diverse 5-position substitutions provided compounds with low nanomolar kinase enzyme inhibition and inhibited the intracellular MAPK pathway.


Archive | 2001

Pyrimidineamines as angiogenesis modulators

Amogh Boloor; Mui GlaxoSmithKline Cheung; Ronda Davis; Philip A. Harris; Kevin GlaxoSmithKline Hinkle; Robert A. Mook; Jeffery Alan Stafford; James Martin Veal


Journal of Medicinal Chemistry | 1995

1-(Fluorobenzyl)-4-amino-1H-1,2,3-triazolo[4,5-c]pyridines: synthesis and anticonvulsant activity.

James L. Kelley; Cecilia S. Koble; Ronda Davis; Ed W. McLean; Francis E. Soroko; Barrett R. Cooper


Journal of Medicinal Chemistry | 2003

Indanylidenes. 1. Design and synthesis of (E)-2-(4,6-difluoro-1-indanylidene)acetamide, a potent, centrally acting muscle relaxant with antiinflammatory and analgesic activity.

David L. Musso; Felicia R. Cochran; James L. Kelley; Ed W. McLean; Jeffrey L. Selph; Greg C. Rigdon; G. Faye Orr; Ronda Davis; Barrett R. Cooper; Virgil L. Styles; James B. Thompson; William R. Hall


Journal of Medicinal Chemistry | 1995

Synthesis and anticonvulsant activity of N-benzylpyrrolo[2,3-d]-, -pyrazolo[3,4-d]-, and -triazolo[4,5-d]pyrimidines: imidazole ring-modified analogues of 9-(2-fluorobenzyl)-6-(methylamino)-9H-purine.

James L. Kelley; Ronda Davis; Ed W. McLean; Robert C. Glen; Francis E. Soroko; Barrett R. Cooper


Journal of Heterocyclic Chemistry | 1990

Synthesis of 6‐[[(hydroxyimino)phenyl]methyl]‐1‐[(1‐methylethyl)sulfonyl]‐1H‐imidazo[4,5‐b]pyridin‐2‐amine. An aza analogue of enviroxime

James L. Kelley; Ed W. McLean; Ronda Davis; Ronald C. Crouch


Archive | 2001

Pyrimidinamines AS ANGIOGENESEMODULATORER

Amogh Boloor; Mui Cheung; Ronda Davis; Philip A. Harris; Kevin Hinkle; Robert A. Mook; Jeffery Alan Stafford; James Martin Veal


Archive | 2001

Pyrimidinamine als angiogenesemodulatoren

Amogh Boloor; Mui GlaxoSmithKline Cheung; Ronda Davis; Philip A. Harris; Kevin GlaxoSmithKline Hinkle; Robert A. Mook; Jeffery Alan Stafford; James Martin Veal


Archive | 2001

Pyrimidineamines as modulators of angiogenesis.

Amogh Boloor; Mui Cheung; Ronda Davis; Philip A. Harris; Kevin Hinkle; Robert A. Mook; Jeffery Alan Stafford; James Martin Veal


Archive | 2001

Pyrimidineamines comme modulateurs de l'angiogenese

Amogh Boloor; Mui Cheung; Ronda Davis; Philip A. Harris; Kevin Hinkle; Robert A. Mook; Jeffery Alan Stafford; James Marvin Veal

Collaboration


Dive into the Ronda Davis's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge